Dendritic cell-based vaccination strategies: Induction of protective immunity against leishmaniasis

Immunobiology

Volumn 204, Issue 5, 2001, Pages 659-666

  Moll, Heidrun ^a   Berberich, Christof ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 12; PROTOZOAL VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; EXPERIMENTAL INFECTION; GENETIC SUSCEPTIBILITY; HEALING; HOST; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; IN VIVO STUDY; LEISHMANIA; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; SPECIES; SYMPTOM; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VACCINATION; VISCERAL LEISHMANIASIS;

EID: 0035711608     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1078/0171-2985-00105     Document Type: Article

References (39)

1. Dendritic cells as sensors of infection
2. Immunobiology of dendritic cells
3. Dendritic cells as vectors for vaccination against infectious diseases
4. Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis
5. The regulation of immunity to Leishmania major
6. Nitric oxide in leishmaniasis
7. IL-4 deficient BALB/c mice resist infection with Leishmania major
8. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response
9. Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis
10. Synthesis, stability, and subcellular distribution of major histocompatibility complex class II molecules in Langerhans cells infected with Leishmania major
11. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response
12. Salmonella infection of bone marrow-derived macrophages and dendritic cells: Influence on antigen presentation and initiating an immune response
13. Entry and survival of Salmonella typhimurium in dendritic cells and presentation of recombinant antigens do not require macrophage-specific virulence factors
14. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans: Implications for initiation of T helper cell immunity in vitro and in vivo
15. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
16. In vivo microbial stimulation induces rapid CD40L-independent production of IL-12 by dendritic cells and their re-distribution to T cell areas
17. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection
18. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: Selective impairment of IL-12 induction in Leishmania-infected cells
19. Leishmania major interferes with antigen presentation by infected macrophages
20. Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages
21. Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells
22. Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells
23. Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses
24. Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major
25. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: Implications for the initiation of anti-Leishmania immunity
26. Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro
27. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells
28. Leishmania major-infected murine Langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous leishmaniasis
29. Dendritic cells as a tool to induce anergic and regulatory T cells
30. Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes
31. Protection against aerosol Mycobacterium tuberculosis infection using Mycobacterium bovis Bacillus Calmette Guérin-infected dendritic cells
32. Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection
33. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable chlamydiae
34. Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo
35. Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection
36. Dendritic cells efficiently induce protective antiviral immunity
37. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
38. Vaccination with Mage-3A1 peptide-pulsed mature, monocyte-derived dentritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
39. Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells